cancel
Showing results for 
Show  only  | Search instead for 
Did you mean: 

Byron Wingerd's Blog

%3CLINGO-SUB%20id%3D%22lingo-sub-531658%22%20slang%3D%22en-US%22%20mode%3D%22NONE%22%20mode%3D%22NONE%22%20mode%3D%22NONE%22%3EPharma%2FBiotech%20Data%20Discovery%20Series%3A%20Sitzung%203%2C%20Design%20of%20Experiments%20(DOE)%20Basics%20using%20Custom%20Designs%3C%2FLINGO-SUB%3E%3CLINGO-BODY%20id%3D%22lingo-body-531658%22%20slang%3D%22en-US%22%20mode%3D%22NONE%22%20mode%3D%22NONE%22%20mode%3D%22NONE%22%3E%3CP%3EDieses%20Journal%20liefert%20Hintergrundinformationen%20zum%20Nachdenken%20%C3%BCber%20DOE-Design%20und%20-Analyse.%3C%2FP%3E%0A%3CP%3EEine%20Schl%C3%BCsselkomponente%20ist%20der%20DOE%20Walkthrough.%20Es%20ist%20eine%20Schritt-f%C3%BCr-Schritt-Anleitung%20f%C3%BCr%20die%20Einrichtung%20Ihres%20ersten%20DOE.%20Es%20ist%20dem%20Tutorial%20unter%20der%20Option%20HILFE%26gt%3BTutorials%26gt%3BDOE-Tutorial%20in%20JMP%20sehr%20%C3%A4hnlich%2C%20aber%20mit%20ein%20paar%20hilfreichen%20Abk%C3%BCrzungen%20und%20einem%20Pharma-Geschmack.%3C%2FP%3E%0A%3CP%3E%26nbsp%3B%3C%2FP%3E%0A%3CP%3E%26nbsp%3B%3C%2FP%3E%3C%2FLINGO-BODY%3E%3CLINGO-TEASER%20id%3D%22lingo-teaser-531658%22%20slang%3D%22en-US%22%3E%3CP%3EDies%20ist%20das%20Journal%20aus%20der%20Pharma-Reihe%20vom%20August%202022%20f%C3%BCr%20die%20Sitzung%20Nr.%203%20%C3%BCber%20DOE.%3CBR%20%2F%3EDas%20Journal%20enth%C3%A4lt%20eine%20DOE-Komplettl%C3%B6sung%20sowie%20ein%20Dashboard%20zur%20Erl%C3%A4uterung%20verschiedener%20Modellbegriffe.%3C%2FP%3E%3C%2FLINGO-TEASER%3E
Choose Language Hide Translation Bar
Byron_JMP
Staff
Pharma/Biotech Data Discovery Series: Session 3, Design of Experiments (DOE) Basics using Custom Designs

This journal provides background for thinking about DOE design and analysis. 

A key component is the DOE Walkthrough. It is a step-by-step guide for setting up your first DOE. Its very similar to the tutorial under the HELP>Tutorials>DOE Tutorial option in JMP, but with a couple of helpful short-cuts and a pharma flavor. 

 

 

Last Modified: Aug 11, 2022 12:47 AM